Literature DB >> 24604141

Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly.

Joan Somja1, Bettina Bisig, Christophe Bonnet, Christian Herens, Reiner Siebert, Laurence de Leval.   

Abstract

Recurrent chromosomal translocations associated to peripheral T-cell lymphomas (PTCL) are rare. Here, we report a case of PTCL, not otherwise specified (NOS) with the karyotype 46,Y,add(X)(p22),t(6;14)(p25;q11) and FISH-proved breakpoints in the IRF4 and TCRAD loci, leading to juxtaposition of both genes. A 64-year-old male patient presented with mild cytopenias and massive splenomegaly. Splenectomy showed diffuse red pulp involvement by a pleomorphic medium- to large-cell T-cell lymphoma with a CD2+ CD3+ CD5- CD7- CD4+ CD8+/- CD30- TCRbeta-F1+ immunophenotype, an activated cytotoxic profile, and strong MUM1 expression. The clinical course was marked by disease progression in the bone marrow under treatment and death at 4 months. In contrast with two t(6;14)(p25;q11.2)-positive lymphomas previously reported to be cytotoxic PTCL, NOS with bone marrow and skin involvement, this case was manifested by massive splenomegaly, expanding the clinical spectrum of PTCLs harboring t(6;14)(p25;q11.2) and supporting consideration of this translocation as a marker of biological aggressiveness.

Entities:  

Mesh:

Year:  2014        PMID: 24604141     DOI: 10.1007/s00428-014-1560-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  17 in total

1.  Detection of translocations involving the HOX11/TCL3-locus in 10q24 by interphase fluorescence in situ hybridization.

Authors:  C Kahl; S Gesk; L Harder; J Harbott; L French; P Deloukas; W Grote; B Schlegelberger; R Siebert
Journal:  Cancer Genet Cytogenet       Date:  2001-08

Review 2.  New biomarkers in T-cell lymphomas.

Authors:  Bettina Bisig; Philippe Gaulard; Laurence de Leval
Journal:  Best Pract Res Clin Haematol       Date:  2012-02-07       Impact factor: 3.020

3.  Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Authors:  Andrew L Feldman; Ahmet Dogan; David I Smith; Mark E Law; Stephen M Ansell; Sarah H Johnson; Julie C Porcher; Nazan Ozsan; Eric D Wieben; Bruce W Eckloff; George Vasmatzis
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

4.  IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases.

Authors:  Anne Pham-Ledard; Martina Prochazkova-Carlotti; Elodie Laharanne; Béatrice Vergier; Thomas Jouary; Marie Beylot-Barry; Jean-Philippe Merlio
Journal:  J Invest Dermatol       Date:  2009-10-08       Impact factor: 8.551

5.  Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.

Authors:  Itziar Salaverria; Claudia Philipp; Ilske Oschlies; Christian W Kohler; Markus Kreuz; Monika Szczepanowski; Birgit Burkhardt; Heiko Trautmann; Stefan Gesk; Miroslaw Andrusiewicz; Hilmar Berger; Miriam Fey; Lana Harder; Dirk Hasenclever; Michael Hummel; Markus Loeffler; Friederike Mahn; Idoia Martin-Guerrero; Shoji Pellissery; Christiane Pott; Michael Pfreundschuh; Alfred Reiter; Julia Richter; Maciej Rosolowski; Carsten Schwaenen; Harald Stein; Lorenz Trümper; Swen Wessendorf; Rainer Spang; Ralf Küppers; Wolfram Klapper; Reiner Siebert
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

6.  Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization.

Authors:  Andrew L Feldman; Mark Law; Karen L Grogg; Erik C Thorland; Stephanie Fink; Paul J Kurtin; William R Macon; Ellen D Remstein; Ahmet Dogan
Journal:  Am J Clin Pathol       Date:  2008-08       Impact factor: 2.493

Review 7.  Splenic involvement by peripheral T-cell and NK-cell neoplasms.

Authors:  John K C Chan
Journal:  Semin Diagn Pathol       Date:  2003-05       Impact factor: 3.464

8.  Tissue microarray-based screening for chromosomal breakpoints affecting the T-cell receptor gene loci in mature T-cell lymphomas.

Authors:  E Leich; E Haralambieva; A Zettl; A Chott; T Rüdiger; S Höller; H-K Müller-Hermelink; G Ott; A Rosenwald
Journal:  J Pathol       Date:  2007-09       Impact factor: 7.996

9.  PVRL2 is translocated to the TRA@ locus in t(14;19)(q11;q13)-positive peripheral T-cell lymphomas.

Authors:  Carole Almire; Philippe Bertrand; Philippe Ruminy; Catherine Maingonnat; Iwona Wlodarska; José I Martín-Subero; Reiner Siebert; Hervé Tilly; Christian Bastard
Journal:  Genes Chromosomes Cancer       Date:  2007-11       Impact factor: 5.006

10.  Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.

Authors:  George Vasmatzis; Sarah H Johnson; Ryan A Knudson; Rhett P Ketterling; Esteban Braggio; Rafael Fonseca; David S Viswanatha; Mark E Law; N Sertac Kip; Nazan Ozsan; Stefan K Grebe; Lori A Frederick; Bruce W Eckloff; E Aubrey Thompson; Marshall E Kadin; Dragana Milosevic; Julie C Porcher; Yan W Asmann; David I Smith; Irina V Kovtun; Stephen M Ansell; Ahmet Dogan; Andrew L Feldman
Journal:  Blood       Date:  2012-08-01       Impact factor: 22.113

View more
  1 in total

1.  Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma.

Authors:  Paolo Corradini; Cristiana Carniti; Martina Magni; Giulia Biancon; Sara Rizzitano; Alessandra Cavanè; Chiara Paolizzi; Matteo Dugo
Journal:  Br J Cancer       Date:  2019-09-02       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.